MedTrace Logo

Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients

NCT00165750 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2013-11-20

No results posted yet for this study

Summary

This study investigate the relationship between regional brain volume measured by MRI and donepezil treatment response in patients with Alzheimer's Disease.

Conditions

Interventions

DRUG

DONEPEZIL HYDROCHLORIDE

One 5mg table, once daily. (After 4 weeks treatment, the dose can be increased 10mg once daily.)

Sponsors & Collaborators

  • Eisai Korea Inc.

    lead INDUSTRY

Principal Investigators

  • Jihee Mun · Eisai Korea Inc.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-03-31
Primary Completion
2008-08-31
Completion
2008-11-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00165750 on ClinicalTrials.gov